Synfini completed $8.9 million Series A Round funding
Sector:
Software
Life Science
AI
08/18/2025
Menlo Park, CA USA
“We’re building the next generation of drug discovery infrastructure,” said Doug Donzelli, CEO of Synfini. “This funding enables us to move faster, go broader with our platform, and deepen our relationships with both biotech innovators and large pharma. We’re grateful to be supported by a syndicate of investors who share our vision, including those who’ve backed us since the very beginning.”
About
Synfini, Inc. is revolutionizing small molecule drug discovery with its AI Cloud Foundry—a platform that integrates artificial intelligence, chemistry automation, and cloud-native workflows to generate better molecules, faster. Founded by domain experts in synthetic chemistry, machine learning, and drug development, Synfini partners with biotech and pharmaceutical companies to bring forward breakthrough therapies with greater speed and precision.
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
